Giverny Capital’s Novo Nordisk NVO Stock Holding History

Giverny Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$456K	Hold	12,400	–	–	0.02%	51
2025 Q4	$631K	Hold	12,400	–	–	0.02%	46
2025 Q3	$688K	Hold	12,400	–	–	0.02%	50
2025 Q2	$856K	Hold	12,400	–	–	0.03%	49
2025 Q1	$861K	Hold	12,400	–	–	0.03%	49
2024 Q4	$1.07M	Hold	12,400	–	–	0.04%	49
2024 Q3	$1.48M	Hold	12,400	–	–	0.06%	43
2024 Q2	$1.77M	Hold	12,400	–	–	0.07%	40
2024 Q1	$1.59M	Hold	12,400	–	–	0.06%	41
2023 Q4	$1.28M	Hold	12,400	–	–	0.06%	44
2023 Q3	$1.13M	Hold	12,400	–	–	0.06%	42
2023 Q2	$1M	Hold	12,400	–	–	0.05%	43
2023 Q1	$987K	Hold	12,400	–	–	0.06%	43
2022 Q4	$839K	Hold	12,400	–	–	0.05%	46
2022 Q3	$618K	Hold	12,400	–	–	0.04%	45
2022 Q2	$691K	Hold	12,400	–	–	0.05%	45
2022 Q1	$689K	Hold	12,400	–	–	0.04%	47
2021 Q4	$694K	Hold	12,400	–	–	0.04%	54
2021 Q3	$595K	Hold	12,400	–	–	0.04%	49
2021 Q2	$519K	Hold	12,400	–	–	0.03%	47
2021 Q1	$418K	Hold	12,400	–	–	0.03%	47
2020 Q4	$433K	Hold	12,400	–	–	0.03%	47
2020 Q3	$430K	Buy	+12,400	New	+$413K	0.04%	47

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Giverny Capital's NVO Position: Q1 2026 in Review

Giverny Capital held its Novo Nordisk (NVO) position steady in Q1 2026 at 12,400 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #51.

Giverny Capital first reported a position in NVO in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.77M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Giverny Capital held 12,400 shares of Novo Nordisk worth $456K as of Q1 2026.
Giverny Capital left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up 0.02% of Giverny Capital's portfolio in Q1 2026, its #51 holding.
Giverny Capital first reported a position in Novo Nordisk in Q3 2020 and has held it in 23 quarters since.
Giverny Capital's Novo Nordisk position peaked at $1.77M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Giverny Capital's 13F filing for Q1 2026, filed 15 May 2026.